News
Genoskin obtains 2014 Young Entrepreneur Award
The Great Economy Awards of 2014 More than 400 people attended the Casino Theatre Barriere in Toulouse for the 6th edition of the Great Economy Award (Grands Prix de l’Economie 2014) on December 8th, 2014. The ceremony was organized by Objectif News in partnership with the French Magazine, La Tribune. During the award ceremony, nine companies and managers were put in the spotlight because of their
Genoskin joins 3R In Vitro Testing Platform IVTIP
Genoskin joins 3R In Vitro Testing Platform Genoskin is proud to join the In Vitro Testing Industrial Platform. The IVTIP Platform was founded in 1993 and currently comprises 46 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies). All members have significant in vitro testing activities. Most of the IVTIP member companies are from Europe, but IVTIP also has members in
Genoskin attends 2014 meeting European Society for Dermatological Research
Genoskin attended the 9th World Congress on Alternatives and Animal use in Life Sciences
Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”
Testing steroid-induced changes related to skin atrophy
We are very pleased to announce that our first publication presenting, in particular, the use of our ex vivo human skin model NativeSkin® came out in July in Archives of Dermatological Research.
Genoskin moving to new offices
Presenting the new offices of Genoskin, located at the Pierre Potier center, an institute of advanced technologies and life sciences, also acting as a business incubator for biotech companies. Genoskin had moved to the new location on July, 2014 and now has access to a fully equipped cell culture laboratory and further facilities spreading on 70 squared meters including biosafety level
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
